Inventor · disambiguated record
John A. Barrett
Also filed as: BARRETT JOHN A · BARRETT JOHN ANDREW
13 granted patents·7 pending applications·326 citations·filing 1994–2024
93Inventor score
Files withBRISTOL MYERS SQUIBB PHARMA CO9SPECTRUM PHARMACEUTICALS INC3DU PONT MERCK PHARMA1DU PONT PHARM CO1MCMURRY THOMAS J1
Top patents by PatentIndex Score
20 records- 0195US6537520B1Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 25, 2003·91 cites·37 claims
- 0293US6800273B2Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Oct 5, 2004·46 cites·25 claims
- 0391US6569402B1Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 27, 2003·24 cites·28 claims
- 0490US6022523ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT PHARM CO·Filed 1997·Granted Feb 8, 2000·46 cites·1 claims
- 0586US6511649B1Vitronectin receptor antagonist pharmaceuticalsFiled 2000·Granted Jan 28, 2003·19 cites·46 claims
- 0680US7332149B1Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 19, 2008·8 cites·5 claims
- 0780US6416733B1Radiopharmaceuticals for imaging infection and inflammationBRISTOL MYERS SQUIBB PHARMA CO·Filed 1997·Granted Jul 9, 2002·56 cites·11 claims
- 0878US7052673B2Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted May 30, 2006·8 cites·22 claims
- 0971US6989139B2Matrix metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 24, 2006·5 cites·24 claims
- 1068US2025121032A1Methods of treating chemotherapy induced neutropenia using fixed doses of g-csf protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1161US12171804B2Methods of treating chemotherapy induced neutropenia using fixed doses of eflapegrastimSPECTRUM PHARMACEUTICALS INC·Filed 2021·Granted Dec 24, 2024·0 cites·9 claims
- 1259US7018611B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 28, 2006·0 cites·26 claims
- 1359US5879657ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT MERCK PHARMA·Filed 1994·Granted Mar 9, 1999·23 cites·70 claims
- 1454US2003007927A1Radiopharmaceuticals for imaging infection and inflammationFiled 2002·Application pending·0 cites
- 1551US7090828B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Aug 15, 2006·0 cites·14 claims
- 1651US2007111947A1Fibrin targeted therapeuticsMCMURRY THOMAS J·Filed 2006·Application pending·0 cites
- 1750US2023277628A1Methods for promoting anti-tumor immune response in a subject in need thereof using encapsulated interleukin 12SPECTRUM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1848US2003152512A1Imaging thrombus with glycoprotein llb/llla antagonistsFiled 2001·Application pending·0 cites
- 1940US2021395773A1In vivo controlled combination therapy for treatment of cancerPRECIGEN INC·Filed 2019·Application pending·0 cites
- 2037US2003124053A1Radiopharmaceuticals for imaging infection and inflammationFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →